Ilex Medical (ILX) Financial Statements
Ilex Medical Financial Overview
Ilex Medical's market cap is currently $540.05M. The company's EPS TTM is $3.47; its P/E ratio is 13.91; and it has a dividend yield of 4.11%. Ilex Medical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 930.83M | $ 920.37M | $ 930.89M | $ 872.54M | $ 1.06B |
| Gross Profit | $ 211.88M | $ 216.31M | $ 231.87M | $ 285.10M | $ 379.38M |
| Operating Income | $ 55.95M | $ 66.72M | $ 82.02M | $ 158.12M | $ 249.95M |
| EBITDA | $ 125.83M | $ 113.12M | $ 123.61M | $ 188.39M | $ 307.85M |
| Net Income | $ 55.55M | $ 38.98M | $ 50.88M | $ 102.12M | $ 197.48M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 231.64M | $ 233.63M | $ 213.26M | $ 224.20M | $ 282.94M |
| Total Assets | $ 992.74M | $ 994.07M | $ 1.02B | $ 899.18M | $ 875.07M |
| Total Debt | $ 46.60M | $ 51.35M | $ 48.27M | $ 51.55M | $ 58.74M |
| Net Debt | $ -128.99M | $ -125.90M | $ -100.12M | $ -149.40M | $ -200.50M |
| Total Liabilities | $ 308.02M | $ 347.58M | $ 392.61M | $ 286.08M | $ 299.49M |
| Stockholders' Equity | $ 684.71M | $ 646.49M | $ 623.51M | $ 613.10M | $ 575.57M |
| Cash Flow | |||||
| Free Cash Flow | $ 42.81M | $ 48.30M | $ 28.27M | $ 41.38M | $ 228.03M |
| Operating Cash Flow | $ 72.87M | $ 81.63M | $ 80.43M | $ 69.74M | $ 270.68M |
| Investing Cash Flow | $ -46.65M | $ -22.94M | $ -90.68M | $ -53.64M | $ -82.45M |
| Financing Cash Flow | $ -27.33M | $ -28.89M | $ -40.72M | $ -77.30M | $ -86.78M |
Currency in ILS
